A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 735 shares of LLY stock, worth $549,787. This represents 0.3% of its overall portfolio holdings.

Number of Shares
735
Previous 712 3.23%
Holding current value
$549,787
Previous $645 Million 1.02%
% of portfolio
0.3%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$772.14 - $960.02 $17,759 - $22,080
23 Added 3.23%
735 $651 Million
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $4,349 - $5,454
-6 Reduced 0.84%
712 $645 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $8,290 - $11,091
14 Added 1.99%
718 $559 Million
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $369,733 - $435,867
704 New
704 $410 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Twin Peaks Wealth Advisors, LLC Portfolio

Follow Twin Peaks Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Peaks Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Twin Peaks Wealth Advisors, LLC with notifications on news.